L. Mantey

Versatile Biosynthetic Engineering of Sialic Acid in Living Cells Using Synthetic Sialic Acid Analogues*

M. Pawlita, W. Reutter, R. Brossmer, 2002, The Journal of Biological Chemistry.

Biochemical engineering of the side chain of sialic acids increases the biological stability of the highly sialylated cell adhesion molecule CEACAM1.

W. Reutter, K. Danker, L. Mantey, 2001, Biochemical and biophysical research communications.

The homozygous M712T mutation of UDP‐N‐acetylglucosamine 2‐epimerase/N‐acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy

K. Yarema, W. Reutter, S. Mitrani‐Rosenbaum, 2004, FEBS letters.

Efficient biochemical engineering of cellular sialic acids using an unphysiological sialic acid precursor in cells lacking UDP‐N‐acetylglucosamine 2‐epimerase

M. Pawlita, W. Reutter, O. Keppler, 2001, FEBS letters.

Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy.

S. Krause, S. Çırak, T. Voit, 2006, Biochemistry.